MEDCX
Price
$11.91
Change
-$0.02 (-0.17%)
Updated
May 22 closing price
Net Assets
6.99B
REBAX
Price
$9.50
Change
-$0.01 (-0.11%)
Updated
May 22 closing price
Net Assets
278.77M
Interact to see
Advertisement

MEDCX vs REBAX

Header iconMEDCX vs REBAX Comparison
Open Charts MEDCX vs REBAXBanner chart's image
MFS Emerging Markets Debt C
Price$11.91
Change-$0.02 (-0.17%)
VolumeN/A
Net Assets6.99B
Columbia Emerging Markets Bond A
Price$9.50
Change-$0.01 (-0.11%)
VolumeN/A
Net Assets278.77M
MEDCX vs REBAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MEDCX vs. REBAX commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MEDCX is a Hold and REBAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MEDCX has more cash in the bank: 6.99B vs. REBAX (279M). MEDCX pays higher dividends than REBAX: MEDCX (5.77) vs REBAX (5.16). MEDCX was incepted earlier than REBAX: MEDCX (23 years) vs REBAX (19 years). MEDCX (1.82) is less costly to investors than REBAX (1.13). MEDCX is a more actively managed with annual turnover of: 58.00 vs. REBAX (41.00). MEDCX has a lower initial minimum investment than REBAX: MEDCX (1000) vs REBAX (2000). REBAX annual gain was more profitable for investors over the last year : 6.37 vs. MEDCX (5.43). REBAX return over 5 years is better than : 11.60 vs. MEDCX (7.77).
MEDCXREBAXMEDCX / REBAX
Total Expense Ratio1.811.13160%
Annual Report Gross Expense Ratio1.821.13161%
Fund Existence23 years19 years-
Gain YTD1.1692.33450%
Front LoadN/A5%-
Min. Initial Investment1000200050%
Min. Initial Investment IRAN/AN/A-
Net Assets6.99B279M2,506%
Annual Yield % from dividends5.775.16112%
Returns for 1 year5.436.3785%
Returns for 3 years16.4718.2190%
Returns for 5 years7.7711.6067%
Returns for 10 years21.4328.3876%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OIGAX34.73N/A
N/A
Invesco Oppenheimer International Gr A
FICGX12.17N/A
N/A
Cantor Fitzgerald Large Cap Fcs Cl A
BMCRX24.67N/A
N/A
BlackRock Advantage Large Cap Gr R
TNVRX16.12N/A
N/A
1290 GAMCO Small/Mid Cap Value R
EMWLX17.34N/A
N/A
Lord Abbett Emerging Markets Equity R6